Anzeige
Mehr »
Login
Mittwoch, 22.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Kursexplosion von 383 % seit November und massiver Solana-Outperformer!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PLBE | ISIN: SE0012675361 | Ticker-Symbol: 6IRA
Frankfurt
22.01.25
09:13 Uhr
1,210 Euro
0,000
0,00 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
IRLAB THERAPEUTICS AB Chart 1 Jahr
5-Tage-Chart
IRLAB THERAPEUTICS AB 5-Tage-Chart

Aktuelle News zur IRLAB THERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
14.01.IRLAB Therapeutics: The Last patient has now Completed the Full Treatment Period in IRLAB's Phase IIb Study with Pirepemat679GOTHENBURG, SE / ACCESSWIRE / January 14, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, January 14, 2025 - IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company that discovers...
► Artikel lesen
29.11.24IRLAB Therapeutics: IRLAB to Present at ABGSC Investor Days on December 4, 2024240GOTHENBURG, SE / ACCESSWIRE / November 29, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, November 29, 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering...
► Artikel lesen
IRLAB THERAPEUTICS Aktie jetzt für 0€ handeln
27.11.24IRLAB Therapeutics: IRLAB to Present at Redeye Technology & Life Science Day on December 3, 2024280GOTHENBURG, SE / ACCESSWIRE / November 27, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, November 27, 2023 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering...
► Artikel lesen
21.11.24IRLAB Therapeutics: Nomination Committee Appointed for IRLAB's Annual General Meeting 2025243GOTHENBURG, SWEDEN / ACCESSWIRE / November 21, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA), a company discovering and developing novel treatments for Parkinson's disease, today announces that...
► Artikel lesen
13.11.24IRLAB Therapeutics: IRLAB to Present at BioStock Life Science Summit 2024282GOTHENBURG, SWEDEN / ACCESSWIRE / November 13, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, November 13, 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company...
► Artikel lesen
04.11.24IRLAB Therapeutics - Progress across the pipeline in Q324418IRLAB's Q324 results highlighted progress across its clinical pipeline. Pirepemat cleared its final safety review and completed patient enrolment in the Phase IIb trial, making way for top-line readouts...
► Artikel lesen
30.10.24IRLAB Therapeutics: IRLAB Publishes Interim Report for the Period January - September 2024274GOTHENBURG, SWEDEN / ACCESSWIRE / October 30, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company discovering and developing novel treatments...
► Artikel lesen
29.10.24IRLAB Therapeutics: IRLAB Reports Continued Progress Ahead of the Mesdopetam Phase III Program237GOTHENBURG, SWEDEN / ACCESSWIRE / October 29, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company discovering and developing novel treatments...
► Artikel lesen
28.10.24IRLAB Therapeutics: IRLAB: Invitation to the Interim Report for Q3 2024 Presentation and Webcast209GOTHENBURG, SWEDEN / ACCESSWIRE / October 28, 2024 / IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company discovering and developing novel treatments for Parkinson's disease, today announced...
► Artikel lesen
18.10.24IRLAB Therapeutics: IRLAB Presents at Redeye Neurology Theme Event293GOTHENBURG, SE / ACCESSWIRE / October 18, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, October 18, 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company discovering...
► Artikel lesen
08.10.24IRLAB Therapeutics - IRL757 progress prompts $2.5m milestone payment270IRLAB Therapeutics has announced that it will receive a $2.5m milestone payment from the McQuade Center for Strategic Research and Development (MSRD), prompted by the dosing of the first participant...
► Artikel lesen
08.10.24IRLAB Therapeutics: IRLAB Receives Milestone Payment of USD 2.5 million in Conjunction with First Dosing in a Phase I Study with IRL757 in Healthy Older Adults300GOTHENBURG, SWEDEN / ACCESSWIRE / October 8, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company discovering and developing novel treatments...
► Artikel lesen
03.10.24IRLAB Therapeutics - IRL757 starts strong in Phase I232IRLAB Therapeutics has announced an encouraging update for the ongoing Phase I trial for IRL757, which is being developed as a potential treatment for apathy. The single ascending dose (SAD) portion...
► Artikel lesen
03.10.24IRLAB's new drug shows promise in treating apathy in Parkinson's patients3
03.10.24IRLAB Therapeutics: Positive Data from the First Part of IRLAB's Phase I Study with the Drug Candidate IRL757295GOTHENBURG, SE / ACCESSWIRE / October 3, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, October 3 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A) - a company discovering...
► Artikel lesen
01.10.24IRLAB Therapeutics - Pirepemat Phase IIb trial completes enrolment246IRLAB Therapeutics has announced the completion of patient enrolment for the Phase IIb trial (React PD) assessing pirepemat's ability to improve balance and reduce falls in Parkinson's disease patients...
► Artikel lesen
30.09.24IRLAB Therapeutics: IRLAB has Enrolled the Last Patient in the Phase IIb Study of Pirepemat216GOTHENBURG, SWEDEN / ACCESSWIRE / September 30, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, September 30, 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company...
► Artikel lesen
25.09.24IRLAB Therapeutics: IRLAB Presents at the International Congress of Parkinson's Disease and Movement Disorders(MDS) 2024308GOTHENBURG, SE / ACCESSWIRE / September 25, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, September 25, 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company that...
► Artikel lesen
18.09.24IRLAB Therapeutics: IRLAB Granted Additional Patent for its Drug Candidate Pirepemat Expanding the Patent Protection in the US281GOTHENBURG, SE / ACCESSWIRE / September 18, 2024 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA) Gothenburg, Sweden, September 18, 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering...
► Artikel lesen
13.09.24IRLAB Therapeutics: IRLAB Participates in Pareto Securities' 15th Annual Healthcare Conference360GOTHENBURG, SE / ACCESSWIRE / September 13, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, September 13, 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company discovering...
► Artikel lesen
Seite:  Weiter >>
58 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1